van Kammen Dp

521 total citations
19 papers, 407 citations indexed

About

van Kammen Dp is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Biological Psychiatry. According to data from OpenAlex, van Kammen Dp has authored 19 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Biological Psychiatry. Recurrent topics in van Kammen Dp's work include Tryptophan and brain disorders (4 papers), Diet and metabolism studies (3 papers) and Schizophrenia research and treatment (3 papers) van Kammen Dp is often cited by papers focused on Tryptophan and brain disorders (4 papers), Diet and metabolism studies (3 papers) and Schizophrenia research and treatment (3 papers) van Kammen Dp collaborates with scholars based in United States van Kammen Dp's co-authors include Bunney We, Goodwin Fk, Post Rm, Post Rm, Walter Lovenberg, Pauline Lerner, Ballenger Jc, J.E. Kleinman, W.E. Bunney and Gillin Jc and has published in prestigious journals such as American Journal of Psychiatry, PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

van Kammen Dp

19 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
van Kammen Dp United States	12	201	141	96	82	55	19	407
Emile D. Risby United States	12	194 1.0×	115 0.8×	93 1.0×	110 1.3×	56 1.0×	25	455
John Rotrosen United States	7	208 1.0×	55 0.4×	41 0.4×	53 0.6×	72 1.3×	8	424
Pantaleo Fornaro Italy	14	126 0.6×	102 0.7×	67 0.7×	76 0.9×	84 1.5×	30	496
Makoto Daiguji Japan	8	73 0.4×	153 1.1×	48 0.5×	129 1.6×	28 0.5×	13	386
Maria J. Sarrias Spain	9	103 0.5×	176 1.2×	83 0.9×	71 0.9×	18 0.3×	9	406
Andreas E. Theodorou United Kingdom	12	132 0.7×	224 1.6×	66 0.7×	124 1.5×	40 0.7×	14	407
Kathleen Price Canada	7	178 0.9×	372 2.6×	83 0.9×	163 2.0×	92 1.7×	10	721
Hady Shimon Israel	9	179 0.9×	105 0.7×	47 0.5×	110 1.3×	20 0.4×	13	413
Kunihiko Tani Japan	10	171 0.9×	240 1.7×	65 0.7×	140 1.7×	39 0.7×	13	460
Nedra Lexow United States	6	189 0.9×	416 3.0×	48 0.5×	191 2.3×	87 1.6×	9	543

Countries citing papers authored by van Kammen Dp

Since Specialization

Citations

This map shows the geographic impact of van Kammen Dp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by van Kammen Dp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites van Kammen Dp more than expected).

Fields of papers citing papers by van Kammen Dp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by van Kammen Dp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by van Kammen Dp. The network helps show where van Kammen Dp may publish in the future.

Co-authorship network of co-authors of van Kammen Dp

This figure shows the co-authorship network connecting the top 25 collaborators of van Kammen Dp. A scholar is included among the top collaborators of van Kammen Dp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with van Kammen Dp. van Kammen Dp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Dp, van Kammen, et al.. (1985). Are there state-dependent markers in schizophrenia?. PubMed. 21(3). 497–502. 19 indexed citations

Targum, Steven D., et al.. (1985). Platelet alpha-adrenergic receptor function in affective disorders and schizophrenia.. PubMed. 21(3). 599–602. 22 indexed citations

Dp, van Kammen, et al.. (1984). The viral hypothesis of schizophrenia: smoke--but is there fire?. PubMed. 20(3). 523–5. 4 indexed citations

Dp, van Kammen, et al.. (1984). Spinal fluid monoamine metabolites and anti-cytomegalovirus antibodies and brain scan evaluation in schizophrenia.. PubMed. 20(3). 519–22. 20 indexed citations

Dp, van Kammen, et al.. (1983). Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.. PubMed. 18(2). 255–9. 3 indexed citations

Dp, van Kammen, et al.. (1983). Cerebrospinal fluid probenecid studies: a reinterpretation.. PubMed. 18(11). 1287–99. 16 indexed citations

Dp, van Kammen, et al.. (1982). Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment.. PubMed. 17(2). 233–42. 49 indexed citations

Dp, van Kammen, et al.. (1981). Lithium and mood change in affective disorder patients.. PubMed. 16(11). 1051–7. 3 indexed citations

Dp, van Kammen, et al.. (1980). alpha-Adrenergic receptor function in schizophrenia.. PubMed. 16(3). 91–4. 17 indexed citations

10.

Dp, van Kammen, et al.. (1980). Effects of dopamine blockade on gonadotropins and testosterone in men. American Journal of Psychiatry. 137(2). 211–214. 29 indexed citations

11.

Dp, van Kammen, et al.. (1979). Measurement of serum neuroleptic concentration by radioreceptor assay: concurrent assessment of clinical psychosis ratings.. PubMed. 3(3). 153–8. 7 indexed citations

12.

Rm, Post, et al.. (1979). CSF calcium: clinical correlates in affective illness and schizophrenia.. PubMed. 14(1). 37–51. 91 indexed citations

13.

Lerner, Pauline, Goodwin Fk, van Kammen Dp, et al.. (1978). Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(6). 685–94. 47 indexed citations

14.

Dp, van Kammen, et al.. (1978). Preliminary evaluation of hydroxylase cofactor in human spinal fluid: potential biochemical and clinical relevance for psychiatric disorders.. PubMed. 14(4). 51–2. 5 indexed citations

15.

Dp, van Kammen, et al.. (1978). Serum prolactin and antipsychotic responses to pimozide in schizophrenia.. PubMed. 14(1). 11–4. 23 indexed citations

16.

Dp, van Kammen, et al.. (1977). Amphetamine-induced catecholamine activation in schizophrenia and depression: behavioral and physiological effects.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16. 655–9. 29 indexed citations

17.

Jc, Gillin, van Kammen Dp, Robert M. Post, & Bunney We. (1977). Effects of prolonged administration of pimozide on sleep-EEG patterns in psychiatric patients.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 1(3). 225–32. 9 indexed citations

18.

Beckmann, H., et al.. (1976). Urinary excretion of 3-methoxy-4-hydroxyphenylglycol in depressed patients: modifications by amphetamine and lithium.. PubMed. 11(4). 377–87. 11 indexed citations

19.

Karoum, Farouk, van Kammen Dp, Bunney We, et al.. (1976). The effect of probenecid on the free and conjugaed 3-methoxy-4-hydroxyphenylglycol (MHPG) in lumbar cerebrospinal fluid.. PubMed. 2(2). 141–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact